Search Login Register

bortezomib (Velcade) Summary

Description: a proteasome inhibitor; structure in first source

Also Known As: Velcade; PS 341; PS-341; PS341 cpd

Networked: 3305 relevant articles (492 outcomes, 854 trials/studies) for this Drug

Key Diseases for which bortezomib is Relevant

  1. Multiple Myeloma : 265 outcomes 349 studies in 1658 results
  2. Neoplasms (Cancer) : 68 outcomes 190 studies in 748 results
  3. Peripheral Nervous System Diseases (PNS Diseases) : 17 outcomes 20 studies in 183 results
  4. Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) : 14 outcomes 31 studies in 186 results
  5. Amyloidosis : 14 outcomes 10 studies in 69 results
Show All >>

Drugs Related to bortezomib

  1. Proteasome Endopeptidase Complex (Proteasome)
  2. Thalidomide (Thalomid)
  3. lenalidomide (CC 5013)
  4. Dexamethasone (Maxidex)
  5. bortezomib (Velcade)
  6. Melphalan (Alkeran)
  7. Cyclophosphamide (Cytoxan)
  8. Doxorubicin (Adriamycin)
  9. Prednisone (Sone)
  10. rituximab (Mabthera)
Show All >>

Therapies Related to bortezomib

  1. Drug Therapy (Chemotherapy)
  2. Stem Cell Transplantation
  3. Transplants (Transplant)
  4. Heterologous Transplantation (Xenotransplantation)
  5. Hematopoietic Stem Cell Transplantation
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.